NEU1 and familial pancreatic carcinoma: Additionally, the therapeutic targeting of Neu-1 with oseltamivir and aspirin with gemcitabine (GEM) treatment significantly disrupts critical signaling mechanisms, tumor progression, and metastasis in a preclinical mouse model of human pancreatic cancer [114].